Back to Awarded Treatment Trials
Awarded Trial: 18T-004
Grant ID
18T-004
Illness
Schizophrenia
Primary Drug/Intervention
probiotic microorganisms
Primary Dosage
4 grams per day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Enrolling
Investigator
Iris Sommer
Sample Size
240
Duration of Study Period for Each Subject
347 days
Outcome Measurements
Functional disability as assessed with the WHO-DAS II Symptom severity as assessed with BPRS Secondary Outcomes: quality of life, recovery, side-effects, peripheral immune markers, presence/severity of parameters of metabolic syndrome
Results
N/A
Publication
N/A
Link
N/A
PI Name
Iris Sommer
Degree
N/A
Center
Neuroscience and Psychiatry
Institution
Unviersity Medical Center Groningen
Address
Deusinglaan 2
City or Town
Groningen
State or Province
N/A
Zip or Postal Code
N/A
Country
Netherlands
Email Address
i.e.c.sommer@umcg.nl